侵襲性真菌感染症の治療のための抗真菌薬 - 抵抗性の増大に直面する限られた治療ツールボックス
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。侵襲性真菌感染症は 世界的な健康上の脅威であり 治療の選択肢は限られており 耐性が高まっています このレビューでは,現在の抗真菌療法,新興の耐性メカニズム,およびこれらの感染と戦うための有望な新薬候補について詳細に述べています.
科学分野
- 医学菌学
- 感染症
- 薬理学について
背景
- 侵襲性真菌感染症 (IFI) は,免疫不全の人口の増加により悪化する,世界的な公衆衛生上の大きな課題です.
- 限られた研究と狭い治療手段は 歴史的に IFIsの効果的な管理を阻害してきた. 特に二形菌によって引き起こされる IFIsは.
- 世界保健機関 (WHO) は,IFIを優先事項として特定し,研究開発の緊急性を強調しました.
研究 の 目的
- IFIに対する現在の抗真菌治療法を検討する.
- 既存の抗真菌剤の発見,物理化学的性質,および構造活動関係について議論する.
- 抗真菌耐性メカニズムと新薬候補を強調する
主な方法
- 現在の抗真菌療法と薬の開発に関する文献レビュー.
- 抗真菌分子の物理化学的性質と構造活動関係の分析
- 抗真菌耐性の分子メカニズムを調べる
主要な成果
- 現在の抗真菌兵器には,ポリエネ,5-フッ素サイトシン,アゾール,エキノカンジンが含まれており,それぞれに制限があります.
- 特にエキノカンジンに対する抗真菌抵抗性の増加は,臨床環境で観察されています.
- WHOが指摘したように,いくつかの新しい抗真菌薬候補が開発中です.
結論
- 抗真菌薬の治療ツールボックスを拡大する必要は極めて重要で,それはIFIの耐性および限られた治療選択肢の増大に起因する.
- 効果的な新しい抗真菌剤の開発には 分子耐性メカニズムを理解することが重要です
- 侵襲性真菌感染症の世界的な脅威に対処するために 継続的な研究と開発が不可欠です
関連する概念動画
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...